Expression analysis of miR-93, miR-122, and miR-192 in patients with coronary artery disease
Experimental Gerontology · 2025
DOI: 10.1016/j.exger.2025.112929 ↗Kurz gefasst
Fachartikel in der Zeitschrift Experimental Gerontology, 2025. Verfasst von Nasim Sohrabifar und 4 weiteren Autor:innen. Beteiligte Einrichtung: Cardiovascular Research Center, Shahid Beheshti University Of Medical Sciences, Tehran, Iran. Hauptthemen laut MEDLINE: MicroRNAs, Coronary Artery Disease. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
BACKGROUND: MicroRNAs (miRNAs) are essential regulators of Coronary Artery Disease (CAD) development and progression. This study investigates the expression profiles of miR-93, miR-122, and miR-192 in CAD patients compared to healthy controls, and their associations with demographic and clinical factors. MATERIAL AND METHODS: Expression levels of miR-93, miR-122, and miR-192 were quantified in 50 CAD patients and 50 age- and gender-matched healthy controls using TaqMan Real-Time PCR. RESULTS: CAD patients had higher expression of miR-93 (2.33-fold, P < 0.0001) and miR-122 (6.14-fold, P < 0.0001) compared to controls, whereas miR-192 showed no significant difference (P = 0.1650). Expressions of miR-93 and miR-122 were correlated with hypertension, diabetes, body mass index (BMI), low-density lipoprotein (LDL), high-density lipoprotein (HDL), and total cholesterol. Additionally, miR-122 was associated with fasting blood glucose (FBG). For miR-192, associations were observed with hypertension, BMI, LDL, and total cholesterol. CONCLUSION: The connections identified between the expression levels of miR-93, miR-122, and miR-192 and lipid-related factors indicate their potential role in pathways that influence lipid regulation. Additionally, the links between miR-93 and miR-122 and diabetes, a key risk factor for CAD, offer compelling perspectives. Of particular interest, miR-122 stands out as a promising diagnostic biomarker for detecting individuals at heightened risk of developing CAD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Cardiovascular Research Center, Shahid Beheshti University Of Medical Sciences, Tehran, Iran.
- Student Research Committee, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran; Department of Medical Genetics, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, I…
- Department of Medical Genetics, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
- Department of Medical Genetics, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran. Electronic address: sghaderian@yahoo.co.uk.
Zitieren
APA
Sohrabifar, N., Vakili, H., Ahmadi, M., Ghafouri-Fard, S., & Ghaderian, S. M. H. (2025). Expression analysis of miR-93, miR-122, and miR-192 in patients with coronary artery disease. Experimental Gerontology. https://doi.org/10.1016/j.exger.2025.112929
Vancouver
Sohrabifar N, Vakili H, Ahmadi M, Ghafouri-Fard S, Ghaderian SMH. Expression analysis of miR-93, miR-122, and miR-192 in patients with coronary artery disease. Experimental Gerontology. 2025. doi:10.1016/j.exger.2025.112929
BibTeX
@article{Sohrabifar2025,
author = {Sohrabifar, Nasim and Vakili, Hosein and Ahmadi, Mohsen and Ghafouri-Fard, Soudeh and Ghaderian, Sayyed Mohammad Hossein},
title = {Expression analysis of miR-93, miR-122, and miR-192 in patients with coronary artery disease},
journal = {Experimental Gerontology},
year = {2025},
doi = {10.1016/j.exger.2025.112929}
}
EUVIMED